FAQ

Madan H. Jagasia

Suggest Changes
Stephanie J. Lee141
Steven Z. Pavletic129
Georgia B Vogelsang127
Mary E. D. Flowers122
Rainer F Storb104
118Stephanie J. Lee
110Mary E. D. Flowers
96Steven Z. Pavletic
90Bipin N. Savani
88Paul J. Martin

Filter Results:

  • Full text PDF available (37)

Publication Year

1996
2018
  • This year (26)
  • Last 5 years (83)
  • Last 10 years (143)

Publication Type

Co-author

Journals and Conferences

Data Set Used

Learn More
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood…
The Blood and Marrow Transplant Clinical Trials Network conducted 2 parallel multicenter phase 2 trials for individuals with leukemia or lymphoma and no suitable related donor. Reduced intensity… (More)
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
PURPOSE Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not offered because of concerns… (More)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The 2014 NIH consensus… (More)